Frontlight ResearchEarly access
Trial site
Saint John's Cancer Institute
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Triple-negative breast cancer3 trials
- Bladder cancer2 trials
- Endometrial cancer2 trials
- Ovarian cancer2 trials
- Brain metastases1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Prostate cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 24 trials
- Phase 12 trials
- Phase 32 trials
- Phase 2/31 trial
- Status
- Recruiting4 trials
- Active, not recruiting3 trials
- Terminated2 trials
- Lead sponsor
- National Cancer Institute (NCI)3 trials
- SWOG Cancer Research Network2 trials
- Agenus Inc.1 trial
- Alliance for Clinical Trials in Oncology1 trial
- Aura Biosciences1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Active, not recruiting
Active, not recruiting
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Triple-negative breast cancer2 recruiting
- Bladder cancer1 recruiting
- Childhood cancers1 recruiting
- Endometrial cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026